SCHEMBL7558208

SCHEMBL7558208

O=C(NN=Cc1c[nH]cn1)c1[nH]c2ccccc2c1-c1ccccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.44
MEN1 O00255 10/20 0.44
KMT2A Q03164 10/20 0.44
LMNA P02545 8/20 0.44
ALDH1A1 P00352 7/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
POLB P06746 2/20 0.44
TP53 P04637 1/20 0.44
KDM4E B2RXH2 7/20 0.43
HTT P42858 2/20 0.43
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
MAPK1 P28482 1/20 0.41
PAX8 Q06710 2/20 0.41
HPGD P15428 1/20 0.41
TUBB4A P04350 2/20 0.41
TUBB P07437 2/20 0.41
TUBA3C P0DPH7 2/20 0.41
TUBA1B P68363 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7558204 1.00 MAPT (0.44) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL7562009 0.84 TUBB4A (0.51) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL7562004 0.84 TUBB4A (0.51) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL7560580 0.81 MAPT (0.57) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL7560577 0.81 MAPT (0.57) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL7561263 0.80 MAPT (0.44) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL7561259 0.80 MAPT (0.44) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL7563579 0.79 MAPT (0.58) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL7563572 0.79 MAPT (0.58) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL7559489 0.78 KMT2A (0.58) MAPTMEN1KMT2ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors ABBOTT LABORATORIES 2002-07-11 US claimed
WO-2002022576-A2 3-SUBSTITUTED INDOLE CARBOHYDRAZIDES USEFUL AS CELL PROLIFERATION AND ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 2002-03-21 WO claimed
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors ABBOTT LABORATORIES 2002-07-11 US disclosed
WO-2002022576-A2 3-SUBSTITUTED INDOLE CARBOHYDRAZIDES USEFUL AS CELL PROLIFERATION AND ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 2002-03-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors MKI67, FLT4, IDO1 MAPT 4828/4885MEN1 3165/4885KMT2A 2765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.